Proteome Sciences PLC (PRM) - Total Liabilities

Latest as of December 2025: GBX17.79 Million GBX ≈ $2.16K USD

Based on the latest financial reports, Proteome Sciences PLC (PRM) has total liabilities worth GBX17.79 Million GBX (≈ $2.16K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Proteome Sciences PLC - Total Liabilities Trend (1994–2025)

This chart illustrates how Proteome Sciences PLC's total liabilities have evolved over time, based on quarterly financial data. See Proteome Sciences PLC current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Proteome Sciences PLC Competitors by Total Liabilities

The table below lists competitors of Proteome Sciences PLC ranked by their total liabilities.

Company Country Total Liabilities
TROUBADOUR RESOURCES INC.
F:2QD0
Germany €325.75K
Walker Crips Group PLC
LSE:WCW
UK GBX23.14 Million
Sutton Harbour Holdings plc
LSE:SUH
UK GBX29.53 Million
Verici Dx Plc
LSE:VRCI
UK GBX2.06 Million
Seed Innovations Ltd
LSE:SEED
UK GBX153.00K
CPPGroup Plc
LSE:CPP
UK GBX22.06 Million
Mothercare PLC
LSE:MTC
UK GBX36.40 Million
Vincerx Pharma, Inc. Common Stock
NASDAQ:VINC
USA $2.62 Million

Liability Composition Analysis (1994–2025)

This chart breaks down Proteome Sciences PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PRM stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.87 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 2.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Proteome Sciences PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Proteome Sciences PLC (1994–2025)

The table below shows the annual total liabilities of Proteome Sciences PLC from 1994 to 2025.

Year Total Liabilities Change
2025-12-31 GBX17.79 Million
≈ $2.16K
+13.12%
2024-12-31 GBX15.72 Million
≈ $1.91K
+8.26%
2023-12-31 GBX14.52 Million
≈ $1.77K
-100.00%
2022-12-31 GBX1.44 Trillion
≈ $175.75 Million
+9.91%
2021-12-31 GBX1.31 Trillion
≈ $159.91 Million
+2.46%
2020-12-31 GBX1.28 Trillion
≈ $156.06 Million
+19.36%
2019-12-31 GBX1.07 Trillion
≈ $130.74 Million
+0.47%
2018-12-31 GBX1.07 Trillion
≈ $130.13 Million
+0.21%
2017-12-31 GBX1.07 Trillion
≈ $129.85 Million
+796.27%
2016-12-31 GBX119.08 Billion
≈ $14.49 Million
-88.70%
2015-12-31 GBX1.05 Trillion
≈ $128.26 Million
-18.41%
2014-12-31 GBX1.29 Trillion
≈ $157.19 Million
+0.96%
2013-12-31 GBX1.28 Trillion
≈ $155.70 Million
+16583717.49%
2012-12-31 GBX7.72 Million
≈ $938.87
+1.40%
2011-12-31 GBX7.61 Million
≈ $925.92
-9.17%
2010-12-31 GBX8.38 Million
≈ $1.02K
-45.73%
2009-12-31 GBX15.44 Million
≈ $1.88K
+27.95%
2008-12-31 GBX12.07 Million
≈ $1.47K
+37.14%
2007-12-31 GBX8.80 Million
≈ $1.07K
+131.04%
2006-12-31 GBX3.81 Million
≈ $463.32
+120.88%
2005-12-31 GBX1.72 Million
≈ $209.76
+12.03%
2004-12-31 GBX1.54 Million
≈ $187.24
-40.43%
2003-12-31 GBX2.58 Million
≈ $314.31
+30.20%
2002-12-31 GBX1.98 Million
≈ $241.41
+60.27%
2001-12-31 GBX1.24 Million
≈ $150.63
-21.40%
2000-12-31 GBX1.57 Million
≈ $191.63
+125.97%
1999-12-31 GBX697.00K
≈ $84.80
-19.14%
1998-12-31 GBX862.00K
≈ $104.88
+56.44%
1997-12-31 GBX551.00K
≈ $67.04
+93.33%
1996-12-31 GBX285.00K
≈ $34.68
-40.63%
1995-12-31 GBX480.00K
≈ $58.40
-30.23%
1994-12-31 GBX688.00K
≈ $83.71
0.00%
1994-10-31 GBX688.00K
≈ $83.71
--

About Proteome Sciences PLC

LSE:PRM UK Diagnostics & Research
Market Cap
$68.28K
GBX561.16 Million GBX
Market Cap Rank
#31372 Global
#1175 in UK
Share Price
GBX1.60
Change (1 day)
+0.00%
52-Week Range
GBX1.28 - GBX3.60
All Time High
GBX22.25
About

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in pla… Read more